Certara (CERT) vs Veeva Systems (VEEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Veeva Systems (VEEV) has outperformed Certara (CERT) over the past year, losing 5.6% versus a loss of 33.5%. Over five years, VEEV leads with a -7.9% price change compared with -77.2% for CERT. Veeva Systems is the larger company by market cap ($46.12 billion vs $1.32 billion), about 35.0 times the size.
On valuation, Certara trades at a lower forward P/E (22.2x vs 27.8x for Veeva Systems).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | VEEV |
|---|---|---|
| Share price | $8.64 | $284.84 |
| Market cap | $1.32B | $46.12B |
| 1-day change | -3.57% | +0.83% |
| YTD return | -1.93% | +27.60% |
| 1-year return | -33.54% | -5.62% |
| 5-year return | -77.17% | -7.95% |
| P/E ratio (TTM) | — | 46.70 |
| Forward P/E | 22.17 | 27.79 |
| EPS (TTM) | $-0.14 | $6.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $3.20B |
| Revenue growth (YoY) | — | +16.34% |
| Net income (latest FY) | — | $908.91M |
| Gross margin | — | 75.53% |
| Operating margin | — | 28.68% |
| Net margin | — | 28.44% |
| 52-week high | $13.11 | $302.17 |
| 52-week low | $4.45 | $148.05 |
| Distance from 52-week high | -34.10% | -5.74% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +0.81% | +3.66% |
| Average volume | 3.10M | 1.66M |
| Shares outstanding | 152.54M | 161.91M |
| Employees | 1,515 | 7,928 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Veeva Systems is about 35.0 times larger than Certara by market value ($46.12B vs $1.32B).
- VEEV has outperformed CERT by 27.9 percentage points over the past year.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Healthcare · Health Information Services · 1,515 employees
About Veeva Systems
VEEV stock →Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Healthcare · Health Information Services · 7,928 employees
CERT vs VEEV FAQ
Which is bigger, Certara or Veeva Systems?
Veeva Systems (VEEV) is larger, with a market capitalization of $46.12B compared with $1.32B for Certara (CERT).
Which stock has performed better over the past year, CERT or VEEV?
VEEV returned -5.62% over the past 12 months, compared with -33.54% for CERT (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Veeva Systems in the same industry?
Yes. Both are classified in the Health Information Services industry within the Healthcare sector.